Cyclophosphamide
Hematopoietic Cell Transplantation
St. Jude Children's Research HospitalSmall moleculePhase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 28/ 100
- Competitive Position
- 89/ 100
Competitive context
5 Active assets in the Hematopoietic Cell Transplantation cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Anti-Thymoglobulin, Rabbit St. Jude Children's Research Hospital | Phase 1 | CC |
Busulphan St. Jude Children's Research Hospital | Phase 1 | CC |
Fludarabine St. Jude Children's Research Hospital | Phase 1 | CC |
Evomela St. Jude Children's Research Hospital | Phase 1 | CC |
FILGRASTIM St. Jude Children's Research Hospital | Phase 1 | CC |
Same molecule, other indications
Cyclophosphamide is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →